Inhalable Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Inhalable Drug Delivery Pipeline Market Report Overview
An inhalable drug delivery device administers medications that are to be inhaled deeply into the lungs. Drugs are delivered either by the nasal or oral respiratory route. The inhalable drug delivery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
| Key Segments | · Nebulizer Systems
· Aqueous Systems |
| Key Territories | · The US
· Europe · China · Australia · Singapore |
| Key Regulatory Paths | · 510(k)
· CE · NMPA · TGA · HSA |
| Leading Companies | · Ablynx NV
· Acorda Therapeutics Inc. · Actervis GmbH · Activoris Medizintechnik GmbH · Aerophase Inc. |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Inhalable Drug Delivery Pipeline Market by Segments
The key segments of the inhalable drug delivery pipeline market are nebulizer systems and aqueous systems. As of September 2024, nebulizer systems accounted for the highest share of pipeline products.
Inhalable Drug Delivery Pipeline Market Analysis by Segments, 2024 (%)
Buy the Full Report for More Segment Insights into the Inhalable Drug Delivery Pipeline Market
Inhalable Drug Delivery Pipeline Market Segmentation by Territories
A few of the key territories with the inhalable drug delivery pipeline market are the US, Europe, China, Japan, Australia, and Singapore. As of September 2024, the US accounted for the highest number of pipeline products.
Inhalable Drug Delivery Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the Inhalable Drug Delivery Pipeline Market
Inhalable Drug Delivery Pipeline Market Segmentation by Regulatory Paths
A few of the key regulatory paths in the inhalable drug delivery pipeline products market are 510(k), CE, NMPA, TGA, and HSA. As of September 2024, 510(k) was the most followed pathway for pipeline products in the inhalable drug delivery market.
Inhalable Drug Delivery Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the Inhalable Drug Delivery Pipeline Market
Inhalable Drug Delivery Pipeline Market – Competitive Landscape
A few of the key companies associated with the inhalable drug delivery pipeline market are Ablynx NV, Acorda Therapeutics Inc., Actervis GmbH, Activoris Medizintechnik GmbH, Aerophase Inc., among others.
Acorda Therapeutics Inc.: Headquartered in Ardsley, New York, the US, it is a biopharmaceutical company that discovers, develops, and markets therapies for treating patients with neurological disorders. The company’s portfolio encompasses marketed products for the treatment of multiple sclerosis (MS). The company sells its products through wholesale pharmaceutical distributors to retail pharmacies and specialty pharmacy providers.
Aerophase Inc.: Headquartered in Longmont, Colorado, the US, it develops pharmaceutical products to treat lung cancer. Aerophase’s patented technology enables the delivery of lipophilic anticancer agents into the lungs. It seeks to work in partnership with pharmaceutical companies and equity investors to develop its products. Aerophase is.
Inhalable Drug Delivery Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Inhalable Drug Delivery Pipeline Market
Segments Covered in the Report
Inhalable Drug Delivery Pipeline Market Segments Outlook (2024)
- Nebulizer Systems
- Aqueous Systems
Inhalable Drug Delivery Pipeline Market Territories Outlook (2024)
- The US
- Europe
- China
- Australia
- Singapore
Inhalable Drug Delivery Pipeline Market Regulatory Paths Outlook (2024)
- 510(k)
- CE
- NMPA
- TGA
- HSA
Scope
This report provides:
- Extensive coverage of the inhalable drug delivery under development.
- An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of inhalable drug delivery and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of inhalable drug delivery under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Acorda Therapeutics Inc
Actervis GmbH
Activoris Medizintechnik GmbH
Acu-Flow Ltd
Aeon Research & Technology
Aerophase Inc
AFT Pharmaceuticals Ltd
Alexza Pharmaceuticals Inc
Baxter International Inc
Bellerophon Therapeutics Inc
Bridgesource Medical Corp
Caddo Medical Technologies LLC
California Northstate University College of Medicine
Canigma A.L LTD
Clyra Medical Technologies Inc
Cognigenics Inc
Creare LLC
Cybin Inc
Department of Biomedical Engineering Columbia University
DesignWise Medical Inc (Inactive)
Edixomed Ltd
Gilbert Technologies BV
HCmed Innovations Co Ltd
HOLLO Medical Inc
iDTx Systems, Inc.
Inhalation Sciences Sweden AB
Invero Pharma LLC
IPI Legacy Liquidation Co
Jupiter Research LLC
KAER Biotherapeutics Corp
Kanabo Research Ltd
LTT Bio-Pharma Co Ltd
Lupin Pharmaceuticals Inc
Marquette University
Medspray BV
Meracle Pte Ltd
Misti Pty Ltd
Monash University
Nemera La Verpilliere
New Air, Inc.
Next Safety, Inc.
Nob Hill Therapeutics Inc
Nobilis Therapeutics Inc
OncoSec Medical Inc
PARI GmbH
Parion Sciences Inc
Pharmosa Biopharm Inc
Qnovia Inc
Rhinomed Ltd
Risproly
RMIT University
Rutgers Cancer Institute of New Jersey
Sandoz International GmbH
Scientific Horizons Consulting LLC
Shenzhen Smoore Technology Ltd
Sino Biopharmaceutical Ltd
SolAeroMed Inc
Stevanato Group SpA
Stirling Pharma Inc
Suzhou Wulian Medical Technology Co Ltd
Suzhou Yihe Pharmaceutical Co Ltd
Technology Commercialization Partners LLC
Teleflex Inc
Tetra Bio-Pharma Inc
Teva Pharmaceutical Industries Ltd
Texas Tech University Health Sciences Center
Third Pole Inc
Tianchen (Tianjin) Biotechnology Co Ltd
Tiziana Life Sciences PLC
University Hospital Southampton NHS Foundation Trust
University of California San Diego
University of Texas Health Science Center at Houston
University of Texas Medical Branch at Galveston
Vectura Group Plc
Vero Biotech LLC
Verona Pharma Plc
Via Therapeutics LLC
Vincent Medical Holdings Ltd
Virpax Pharmaceuticals Inc
VistaGen Therapeutics Inc
VitalMIST
Wellfully Ltd
Wellinks Inc
Windtree Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which segment had the highest share in the inhalable drug delivery pipeline market as of September 2024?
As of September 2024, nebulizer systems accounted for the highest share of the inhalable drug delivery pipeline products.
-
Which territory had the highest number of products in the inhalable drug delivery pipeline market as of September 2024?
As of September 2024, the US accounted for the highest number of pipeline products in the inhalable drug delivery market.
-
Which was the most followed regulatory pathway in the inhalable drug delivery pipeline market as of September 2024?
As of September 2024, 510(k) was the most followed pathway for pipeline products in the inhalable drug delivery market.
-
Which are the major companies operating in the inhalable drug delivery pipeline market?
A few of the key companies associated with the inhalable drug delivery pipeline market are Ablynx NV, Acorda Therapeutics Inc., Actervis GmbH, Activoris Medizintechnik GmbH, Aerophase Inc., among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Sample Report
Inhalable Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Inhalable Drug Delivery reports
